Oricon Inc. Logo

Oricon Inc.

Provides entertainment industry data, music charts, web media, and marketing services.

4800 | T

Overview

Corporate Details

ISIN(s):
JP3200140006
LEI:
Country:
Japan
Address:
港区六本木六丁目8番10号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Oricon Inc. is a research and data company focused on transforming facts into intelligence from an objective standpoint. The company operates across three primary business segments. Its Data Providing Business is widely recognized for supplying marketing data and statistics for the entertainment industry, including its influential music charts and comprehensive music databases for e-commerce and broadcasting. The Communication Business manages web media outlets such as 'ORICON NEWS' and 'ORICON Customer Satisfaction' and provides PR and web marketing consulting. The Advertising Business handles the planning and operation of advertising and events. Through these integrated activities, Oricon delivers key insights to both corporate and individual clients, primarily within the entertainment and media sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 07:31
Registration Form
確認書
Japanese 8.1 KB
2025-11-07 07:30
Interim Report
半期報告書-第27期(2025/04/01-2026/03/31)
Japanese 186.9 KB
2025-06-27 08:31
Post-Annual General Meeting Information
臨時報告書
Japanese 22.1 KB
2025-06-26 08:41
Governance Information
内部統制報告書-第26期(2024/04/01-2025/03/31)
Japanese 25.0 KB
2025-06-26 08:39
Registration Form
確認書
Japanese 7.9 KB
2025-06-26 08:38
Annual Report
有価証券報告書-第26期(2024/04/01-2025/03/31)
Japanese 881.7 KB
2025-05-14 08:08
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.2 KB
2025-04-14 09:52
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.3 KB
2025-03-14 09:05
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.2 KB
2024-11-07 07:35
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-11-07 07:34
Interim Report
半期報告書-第26期(2024/04/01-2025/03/31)
Japanese 185.6 KB
2024-06-27 08:00
Post-Annual General Meeting Information
臨時報告書
Japanese 22.1 KB
2024-06-26 08:05
Governance Information
内部統制報告書-第25期(2023/04/01-2024/03/31)
Japanese 23.0 KB
2024-06-26 08:04
Registration Form
確認書
Japanese 8.0 KB
2024-06-26 08:02
Annual Report
有価証券報告書-第25期(2023/04/01-2024/03/31)
Japanese 840.0 KB

Automate Your Workflow. Get a real-time feed of all Oricon Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Oricon Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Oricon Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.